Literature DB >> 27272003

[Effect of the body mass index on outcomes of ureterorenoscopy for renal stones].

F Schott1, S Knipper2, A K Orywal2, A J Gross2, C Netsch2.   

Abstract

BACKGROUND: Purpose of this work is to compare the outcome of ureterorenoscopy (URS) with regard to stone-free rates (SFR) and complication rates (CR) in patients with different body mass index (BMI) scores for the treatment of kidney stones.
MATERIALS AND METHODS: A retrospective chart review of all patients with known BMI, who underwent URS for kidney stones between 2006 and 2012 at our institution, was performed (n = 556 patients). The SFR and CR of obese patients were compared to overweight and normal weight patients.
RESULTS: Mean age was 52.51 years and the average BMI 27.74 kg/m2. Of the patients, 34.2 % had normal weight (22.59 ± 1.91 kg/m2), 39.6 % were overweight (27.30 ± 1.42 kg/m2), and 26.3 % were obese (35.09 ± 5.93 kg/m2). The mean ASA score differed significantly between normal weight (1.99 ± 0.57), overweight (2.03 ± 0.62), and obese (2.22 ± 0.63) patients (p ≤ 0.036). The mean stone size was 8.51 ± 6.84 mm and the mean number of stones per patient 1.9 ± 2.41, whereby the differences between groups was not significant. There were no differences between the groups regarding the use of preoperative (94.8 %) and postoperative ureteral stents (60.3 %), the Ho:YAG laser (33.6 %), the use of flexible (16.2 %) or semirigid/flexible URS (59.4 %), and the mean operative time (52.04 ± 34.55 min). There were no differences in the SFR for the upper (90 %), mid (94.7 %), and lower pole (90.2 %), multiple location (68.6 %) or the total SFR (86.3 %). Total SFR of 95.7, 88.4, and 73.7 % for urinary calculi < 5 mm, 5-9 mm, and ≥ 10 mm, respectively, were found and the differences between the patient groups was not significant. The CR was 10.4 % (differences between the patient groups not significant).
CONCLUSION: URS is an appropriate treatment for renal stones with high SFR and low CR regardless of patient's BMI.

Entities:  

Keywords:  Clavien classification; Complication rate; Nephrolithiasis; Obesity; Stone free rate

Mesh:

Year:  2016        PMID: 27272003     DOI: 10.1007/s00120-016-0132-3

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  31 in total

Review 1.  The impact of obesity on surgical outcomes: a review.

Authors:  P S Choban; L Flancbaum
Journal:  J Am Coll Surg       Date:  1997-12       Impact factor: 6.113

2.  Ureterorenoscopy with holmium-yttrium-aluminum-garnet fragmentation is a safe and efficient technique for stone treatment in patients with a body mass index superior to 30 kg/m2.

Authors:  Gregory Delorme; Yann Nguyen Huu; Julien Lillaz; Stéphane Bernardini; Eric Chabannes; Guillaume Guichard; Hugues Bittard; François Kleinclauss
Journal:  J Endourol       Date:  2012-01-12       Impact factor: 2.942

3.  Obesity, weight gain, and the risk of kidney stones.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  JAMA       Date:  2005-01-26       Impact factor: 56.272

4.  [Valdivia supine position as the best option for percutaneous surgery of renal calculi in morbidly obese patients].

Authors:  L A Fariña Pérez; E R Zungri Telo
Journal:  Actas Urol Esp       Date:  2005 Nov-Dec       Impact factor: 0.994

5.  Prevalence of kidney stones in the United States.

Authors:  Charles D Scales; Alexandria C Smith; Janet M Hanley; Christopher S Saigal
Journal:  Eur Urol       Date:  2012-03-31       Impact factor: 20.096

6.  Extracorporeal shock wave lithotripsy in the treatment of renal pelvicalyceal stones in morbidly obese patients.

Authors:  V A Mezentsev
Journal:  Int Braz J Urol       Date:  2005 Mar-Apr       Impact factor: 1.541

7.  Body size and 24-hour urine composition.

Authors:  Eric N Taylor; Gary C Curhan
Journal:  Am J Kidney Dis       Date:  2006-12       Impact factor: 8.860

8.  The impact of body mass index on the outcomes of retrograde intrarenal stone surgery.

Authors:  Turhan Caskurlu; Gokhan Atis; Ozgur Arikan; Eyup Sabri Pelit; Mert Kilic; Cenk Gurbuz
Journal:  Urology       Date:  2013-03       Impact factor: 2.649

9.  Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients.

Authors:  Wesley O Ekeruo; Yeh Hong Tan; Matthew D Young; Philipp Dahm; Michaella E Maloney; Barbara J Mathias; David M Albala; Glenn M Preminger
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

10.  Impact of preoperative ureteral stenting on stone-free rates of ureteroscopy for nephroureterolithiasis: a matched-paired analysis of 286 patients.

Authors:  Christopher Netsch; Sophie Knipper; Thorsten Bach; Thomas R W Herrmann; Andreas J Gross
Journal:  Urology       Date:  2012-10-18       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.